Regulation of Th-POK and Runx3 in T cell development in human thymoma

Autoimmunity

Volumn 42, Issue 8, 2009, Pages 653-660

  Tokunaga, Toshiteru ^a   Hayashi, Akio ^a   Kadota, Yoshihisa ^a   Shiono, Hiroyuki ^a   Inoue, Masayoshi ^a   Sawabata, Noriyoshi ^a   Okumura, Meinoshin ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Human thymus; MRNA; Runx3; Th POK; Thymoma

Indexed keywords

MESSENGER RNA; TH POK; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CHILD; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFANT; IRRADIATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; THYMECTOMY; THYMOMA; THYMUS; TUMOR CELL;

ADULT; AGED; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; THYMOMA; THYMUS GLAND; TRANSCRIPTION FACTORS;

EID: 70449450432     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916930903120941     Document Type: Article

References (38)

1. Levine GD, Rosai J. Thymic hyperplasia and neoplasia: A review of current concepts. Hum Pathol 1978;9:495-515.
2. Willcox N. Myasthenia gravis. Curr Opin Immunol 1993;5: 910-917.
3. Levinson AI, Wheatley LM. The thymus and the pathogenesis of myasthenia gravis. Clin Immunol Immunopathol 1996;78: 1-5.
4. Palestro G, Geuna M, Novero D, Godio L, Ciccone G, Azzoni L. Immunophenotype of thymoma-associated lymphoid cell component of T-cell type. A new analytic procedure in keeping with structural heterogeneities. Virchows Arch B Cell Pathol 1990;59:297-304.
5. Fujii Y, Hayakawa M, Inada K, Nakahara K. Lymphocytes in thymoma: Association with myasthenia gravis is correlated with increased number of single-positive cells. Eur J Immunol 1990;20:2355-2358.
6. Fujii Y, Hayakawa M, Nakahara K. Thymus cells in myasthenia gravis: A two-color flow cytometric analysis of lymphocytes in the thymus and thymoma. J Neurol 1992;239: 82-88.
7. Inoue M, Okumura M, Fujii Y, Miyoshi S, Shiono H, Fukuhara K, Kadota Y, Matsuda H. Immaturity of lymphocytes in the metastatic lesions of thymoma. Clin Immunol Immunopathol 1998;88:249-255.
8. + cells in vitro. Clin Exp Immunol 1998;112:419-426.
9. +CD82 single-positive cells that lack CD69 in epithelial cell tumors of the human thymus. Cell Immunol 1995;161:181-187.
10. Inoue M, Okumura M, Miyoshi S, Shiono H, Fukuhara K, Kadota Y, Shirakura R, Matsuda H. Impaired expression of MHC class II molecules in response to interferon-gamma (IFN- g) on human thymoma neoplastic epithelial cells. Clin Exp Immunol 1999;117:1-7.
11. He X, He X, Dave VP, Zhang Y, Hua X, Nicolas E, Xu W, Roe BA, Kappes DJ. The zinc finger transcription factor Th- POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 2005;433:826-833.
12. Sun G, Liu X, Mercado P, Jenkinson SR, Kypriotou M, Feigenbaum L, Galéra P, Bosselut R. The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat Immunol 2005;6:373-381.
13. Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C, Okuda T, Taniuchi I. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 2008;319:822-825.
14. Wildt KF, Sun G, Grueter B, Fischer M, Zamisch M, Ehlers M, Bosselut R. The transcription factor Zbtb7b promotes CD4 expression by antagonizing Runx-mediated activation of the CD4 silencer. J Immunol 2007;179: 4405-4414.
15. Muroi S, Naoe Y, Miyamoto C, Akiyama K, Ikawa T, Masuda K, Kawamoto H, Taniuchi I. Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate. Nat Immunol 2008;9:1113-1121.
16. Egawa T, Littman DR. ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. Nat Immunol 2008;9: 1131-1139.
17. Masaoka A, Monden Y, Nakahara K, Tanioka T. Followup study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-2492.
18. World Health Organization Classification of Tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon: International Agency for Research on Cancer (IARC) Press; 2004.
19. Okumura M, Fujii Y, Miyoshi S, Shiono H, Inoue M, Kadota Y, Fukuhara K, Matsuda H. Three-color flow cytometric study on lymphocytes derived from thymic diseases. J Surg Res 2001;101:130-137.
20. Inoue M, Fujii Y, Okumura M, Takeuchi Y, Shiono H, Miyoshi S, Matsuda H, Shirakura R. Mature CD4 single positive thymocytes in human Thymoma: T cell may differentiate in the thymic epithelial cell tumor. Pathobiology 1997;65:216-222.
21. Kadota Y, Okumura M, Miyoshi S, Kitagawa-Sakakida S, Inoue M, Shiono H, Maeda Y, Kinoshita T, Shirakura R, Matsuda H. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN- g). Clin Exp Immunol 2000;121:59-68.
22. + T cells. Nat Immunol 2008;10:1122-1130.
23. Nawijin MC, Ferreira R, Dingjan GM, Kahre O, Drabek D, Karis A, Grosveld F, Hendriks RW. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice. J Immunol 2001;167:714-723.
24. Hernández-Hoyos G, Anderson MK, Wang C, Rothenberg EV, Alberola-Ila J. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity 2003;19:83-94.
25. Pai SY, Truitt ML, Ting CN, Leiden JM, Glimcher LH, Ho IC. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 2003;19:863-875.
26. Woolf E, Xiao C, Fainaru O, Lotem J, Rosen D, Negreanu V, Bernstein Y, Goldenberg D, Brenner O, Berke G, et al. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc Natl Acad Sci USA 2003;100:7731-7736.
27. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T, Ito Y, Littman DR. Differential requirements for Runx protein in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 2002;111:621-633.
28. Inada K, OkumuraM, Shiono H, Inoue M, Kadota Y, Ohta M, Matsuda H. Role of positive of thymoma-associated T cells in the pathogenesis of myasthenia gravis. J Surg Res 2005;126: 34-40.
29. Okumura M, Fujii Y, Shiono H, Inoue M, Minami M, Utsumi T, Kadota Y, Sawa Y. Immunological function of thymoma and pathogenesis of pareneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg 2008;56:143-150.
30. Ströbel P, Chuang WY, Chuvpilo S, Zettl A, Katzenberger T, Kalbacher H, Riekmann P, Nix W, Schalke B, Gold R, et al. Commom cellular and diverse genetic basis of thymomaassociated myasthenia gravis: Role of MHC class II and AIRE genes and genetic polymorphisms. Ann N Y Acad Sci 2008; 1132:143-156.
31. Nakajima J, Murakawa T, Fukami T, Sano A, Takamoto S, OhtsuH.Postthymectomymyastheniagravis: Relationshipwith thymoma and antiacetyllcholine receptor antibody. Ann Thorac Surg 2008;86:941-945.
32. + T cells are generated by the thymoma in myasthenia gravis. Ann Neurol 2001;50: 64-72.
33. Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, NixW, Kiefer R, Müller-Hermelink HK, Marx A. Thymomas alter the T-cell subset composition in the blood: A potential mechanism for thymoma-associated autoimmune disease. Blood 2000;96:3872-3879.
34. + T cells in thymomas. Blood 2002;100:159-166.
35. De Rosa SC, Herzenberg LA, Herzenberg LA, Roederer M. 11-Color, 13-parameter flow cytometry: Identification of human naïve T cells by phenotype, function, and T-cell receptor diversity. Nat Med 2001;7:245-248.
36. + T cells contain cells with high levels of lymphocytes functionassociated antigen-1 expression, a phenotype of primed T cells. J Immunol 1993;150:429-437.
37. + thymocyte selection by a single MHC class II/ peptide ligand affected by its expression level in the thymus. Immunity 1997;6:401-410.
38. Hogquist KA, Jameson SC, Heath WR, Howard JL, BevanMJ, Carbone FR. T cell receptor antagonist peptide induce positive selection. Cell 1994;76:17-27.